Jan 272020
Download the abstract book: 4th IAAASS ABSTRACT-BOOK
2018.09.24 | ||||
5.00 pm | Registration | |||
6.00 pm | Remarks | |||
EnzoTramontano | Organizing Committee Coordinator | |||
Giorgio Palù | President of the European Society for Virology and of the Società Italiana di Virologia Italian Society for Virology – SIV-ISV | |||
José Esté | President of the International Society for Antiviral Research | |||
Inaugural Lecture | ||||
José Esté | Host-pathogen interactions and antiviral drug potency | |||
Fundaciò Irsicaixa (Spain) | ||||
2018.09.25 | ||||
9.00 am | Plenary lectures | |||
Stephan Ludwig | Structural Targeting signal transduction pathways to fight the flu | |||
University of Münster, Germany | ||||
Stuart Le Grice | Small molecule targeting of viral RNA regulatory elements | |||
National Cancer Institute (USA) | ||||
11.00-11.15 am | Coffee Break | |||
11.15 am | Plenary lectures | |||
Andrea Brancale | Computer-aided design of novel antivirals | |||
Cardiff University (UK) | ||||
Giorgio Palù | Functionality and druggability of the E6 oncoprotein of HPV | |||
University of Padova | ||||
1.00-2.00 pm | Lunch | |||
2.00-3.30 pm | Poster session 1 | |||
3.30-5.00 pm | Selected oral communications | |||
6.00 pm | Coffee break | |||
6.30-7.30 pm | Discussion groups | |||
2018.09.26 | ||||
9.00 am | Plenary lectures | |||
Raffaele De Francesco | From the elucidation of HCV life-cycle to the development of highly effective antivirals | |||
INGM, Italy |
||||
Vincenzo Summa | Discovery of Grazoprevir an HCV pangenotype protease inhibitor approved for interferon free therapy to cure the HCV infected patients | |||
IRBM (Italy) | ||||
11.00-11.15 am | Coffee Break | |||
11.15 am | Round table: Working in a company after the PhD
Timothy Tellinghuisen (Hoffmann-La Roche) Vincenzo Summa (IRBM) Stuart Le Grice (NCI) Franco Lori (Virostatics) |
|||
1.00-2.00 pm | Lunch | |||
2.00-3.30 pm | Poster session and Bio-tech companies presentation desk | |||
3.30-5.00 pm | Selected oral communications | |||
6.00 pm | Coffee break | |||
6.30-7.30 pm | Discussion groups | |||
2018.09.27 | ||||
9.00 am | Plenary lectures | |||
Zlatko Janeba | The progress in development of inhibitors of viral reverse transcriptase | |||
University of Prague, Czech Republic | ||||
Michelle Hastings | Therapeutic Targeting of Gene Expression with Antisense | |||
Rosalind Franklin University, USA | ||||
11.00-11.15 am | Coffee Break | |||
11.15 am | Plenary lectures | |||
Reuben Harris | Targeting Evolvability | |||
University of Minnesota (USA) | ||||
Maurizio Botta | Antiviral compounds with broad spectrum activity on enveloped viruses | |||
University of Siena (Italy) | ||||
1.00 pm | Lunch | |||
Free afternoon | ||||
2018.09.28 | ||||
9.00 am | Plenary lectures | |||
Thomas Mertens | Re-emergence of antibodies in antiviral therapy | |||
University of Ulm (Germany) | ||||
Daniel Appella | Disrupting HIV Nucleocapsid Protein with Mercaptobenzamides | |||
NIH (USA) | ||||
11.00-11.15 am | Coffee Break | |||
11.15 am | Plenary lectures | |||
Graciela Andrei | Viral DNA polymerases: effects of amino acid substitutions on viral adaptation and evolution | |||
KU Leuven (Belgium) | ||||
Simona Distinto | In silico virtual screening approaches for antiviral drug discovery | |||
University of Cagliari (Italy) | ||||
1.00-2.00 pm | Lunch | |||
2.00-3.00 pm | Poster session | |||
3.00-5.00 pm | Selected oral communications | |||
6.00 pm | Coffee break | |||
6.30-7.30 pm | Discussion groups | |||
2018.09.29 | ||||
Breakfast and leaving |